Changes of Blood Chemistry by Experimental Cystic Duct Obstruction

실험적 담도폐색에 의한 혈액화학치의 변화

  • Lee, Hae-Beom (College of Veetrinary Medicine, Brain Korea 21, Bio-Safety Research Institute, Chonbuk National University) ;
  • Lee, Byung-Gon (Shinpung Animal Clinic) ;
  • Chon, Seung-Ki (Wow Animal Clinic) ;
  • Kim, Nam-Soo (College of Veetrinary Medicine, Brain Korea 21, Bio-Safety Research Institute, Chonbuk National University)
  • 이해범 (전북대학교 수의과대학, Post-BK21, 생체안전성연구소) ;
  • 이병곤 (신풍동물병원) ;
  • 전승기 (와우동물병원) ;
  • 김남수 (전북대학교 수의과대학, Post-BK21, 생체안전성연구소)
  • Published : 2008.10.31

Abstract

The aim of this study was to establish an experiment animal model for easy diagnosis and monitoring effect of treatment of cholelithiasis by cholesterol and mixed gall stone. In 12 adult beagle dogs, five dogs there were in the control group and seven dogs in the experiment group with ligated cystic duct. General clinical signs were recorded, CBC and blood chemistry were examined. Control group and experiment group were evaluated every 2 weeks for a period of 20 weeks. The results were (1) Total blirubin, cholesterol, alanine aminotransferase (ALT), aspartate aminotransferase (AST) activity were significantly higher in the experiment group with ligated cystic duct than control group during 2-8 weeks. (2) Total alkaline phosphatase (TALP) activity was significantly higher when compare with control group during 2-8 weeks. Bone alkaline phosphatase(BALP) activity was increased slightly between 2 and 8 weeks but was decreased between 10 and 20 weeks. (3) Blood urea nitrogen (BUN) was decreased between 2 and 8 weeks. After 10 weeks, this was in normal range. (4) On complate blood count (CBC), $Ca^{2+}$ and P were not changed until 20 weeks. (5) On clinical signs in experimental group, they observed a depression, yellow color of mucus membrane and conjunctiva, xanthinuria and xanthochromic. The present study showed that the experimental animal model with ligated cystic duct was a useful model to study biliary tract disease.

Keywords

References

  1. Barr F. Barnet A. Disorders of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 1992; 90: 589
  2. Center S A, Castleman W, Roth L, Baldwin B H and Tennant B C. Light microscopic and electron microscopic changees in the livers of cats with extrahepatic bile duct obstruction. Am J Vet Res 1986; 47: 1278-1282
  3. Chowdury JR. Chowdury NR. Unveiling the mysteries of inherited disorders of bilirubin glucuronidation. Gastroenterolgy 1993; 105: 288 https://doi.org/10.1016/0016-5085(93)90041-A
  4. DeNovo R C and Prasse K W. Comparison of serum biochemical and hepatic functional alterations in dogs treated with corticosteroids and hepatic duct ligation. Am J Vet Res 1983; 44: 1703-1709
  5. Ebeling PR, Peterson JM, Riggs BL. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone disease. J bone and mineral Res 1992; 7: 1243-1258
  6. Endo T. Bile acid metabolism in benign recurrent intrahepatic cholestasis. Gastroenterology 1979; 76: 1002
  7. Fevery J. Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease. J Clin Invest 1977; 60: 970 https://doi.org/10.1172/JCI108877
  8. Hirano K, Matsumoto H, Tsuyoshi T. Specific assays for human alkaline Phosphatase isozymes. Clin Chemica Acta 1987; 166: 265-273 https://doi.org/10.1016/0009-8981(87)90429-3
  9. Holzbach RT. Biliary proteins, Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 1984; 72: 35
  10. Hootegem PV. Serum bilirubins in hepatobiliary disease. Comparison with other liver function tests and changes in the postobstructive period. Hepatology 1985; 5: 112 https://doi.org/10.1002/hep.1840050123
  11. Hori M, Takahashi H, Konno T. A classification of in vivo bone labels after double labeling in canine bones. Bone 1985; 6: 147-154 https://doi.org/10.1016/8756-3282(85)90047-X
  12. Klein L, Lafferty FW, Pearson OH. Correlation of urinary hydroxyproline, serum alkaline phosphatase and skeletal calcium turnover. Metabolism 1964; 13: 272-284 https://doi.org/10.1016/0026-0495(64)90106-4
  13. McLean FM, Keller PJ, Genge BR. Disposition of preformed mineral in matrix vesicles. The journal of biological chemistry 1987; 262(22): 10481-10488
  14. Melkko J, Niemi S, Risteli L. Radioimmunoassy of the carboxyterminal propeptide of human type I procollagen. Clin chem 1990; 36(7): 1328-1332
  15. Meyers WC. A prospective analysis of 1518 laparoscopic cholecystectomies. N Engl J Med 1991; 324: 1073 https://doi.org/10.1056/NEJM199104183241601
  16. Monsigny M, Roche AC, Sene C. Suger-lectin interaction: How does wheat-germ agglutinin bind sialoglycoconjugaetes? Eur Biochem 1980; 104: 147-153 https://doi.org/10.1111/j.1432-1033.1980.tb04410.x
  17. Moss DW. Alkaline phosphatase iosenzyme. Clin Chem 1982; 10: 2007-2016
  18. Podda M. Efficacy and safety of a combination of dienodeoxycholic acid and ursodeoxycholic acid for gallstone dissulution. Gastroenterology 1989; 96: 222 https://doi.org/10.1016/0016-5085(89)90784-1
  19. Porayko MK. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 1990; 98: 1594 https://doi.org/10.1016/0016-5085(90)91096-O
  20. Price PA, Parthemore JG, Deftos LJ. New biochemical marker for bone metabolism. J Clin Invest 1980; 66: 878-883 https://doi.org/10.1172/JCI109954
  21. Ransohoff DF. Assessment of prophylactic cholecystectomy and medical therapy for diabetics with silent gallstones. Gastroenterology 1987; 92: 1588
  22. Ritter JK. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyl transferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J Clin Invest 1992; 90: 150 https://doi.org/10.1172/JCI115829
  23. Rosenthal P. Homozygous Dubin-Johnson syndrome exhibits a charateristic serum bilirubin pattern. Hepatology 1981; 1: 540
  24. Sauerbruch T. Fragmentation of bile duct stones by extracorporeal shock waves. Gastroenterology 1989; 96: 222 https://doi.org/10.1016/0016-5085(89)90784-1
  25. Sorensen S. Wheat-Germ agglutinin method for measuring bone and liver isoenzymes of alkaline phosphatase assessed in postmenopausal osteoporosis. Clin Chem 1988; 34(8): 1636-1640
  26. Thistle JL. Dissolution of cholesterol gallbladder stones by methyl-tert-butyl ether administered by percutaneous transhepatic catheter. N Engl J Med 1989; 320: 633 https://doi.org/10.1056/NEJM198903093201004